Kashiwa, Japan

Yoshiyuki Yamamoto


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Contributions of Yoshiyuki Yamamoto in Monoclonal Antibody Development

Introduction

Yoshiyuki Yamamoto is a prominent inventor based in Kashiwa, Japan, known for his significant contributions to the field of biotechnology. With a focus on therapeutic advancements, he has developed innovative solutions that hold promise for treating various medical conditions.

Latest Patents

Yamamoto holds a noteworthy patent for an anti-tissue factor monoclonal antibody. This patent includes monoclonal antibodies against human and mouse tissue factor, as well as fragments thereof. Additionally, it covers pharmaceutical compositions and formulations designed for drug delivery that incorporate these antibodies. Therapeutic methods utilizing these inventions are also highlighted in his patent, showcasing their potential in medical applications.

Career Highlights

Throughout his career, Yamamoto has been affiliated with prestigious institutions, such as the National Cancer Center and The University of Tokyo. His work within these organizations has allowed him to contribute significantly to research and development in cancer treatment and therapeutic strategies.

Collaborations

Yamamoto has collaborated with notable colleagues like Yasuhiro Matsumura and Masahiro Yasunaga. Together, their cooperative efforts have advanced the field of monoclonal antibody research and development, demonstrating the importance of teamwork in scientific innovation.

Conclusion

Yoshiyuki Yamamoto's contributions to the field of biotechnology, through his patent on anti-tissue factor monoclonal antibodies, exemplify the impact of innovative research in medicine. His collaborations and work with leading institutions underscore his commitment to advancing therapeutic methods and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…